BHI Therapeutic Sciences provides access to stem cell therapies to patients who may benefit from these treatments. We engage in collaborative relationships with leading institutions, scientists, and physicians across the globe.

We only utilize stem cells from either your own body (autologous) or from umbilical cord donors who have proceeded through a multiple step testing process that ensures stem cell patient safety. We do not use embryonic stem cells, nor will we ever.

BHI Therapeutic Sciences has US board-certified physicians on staff for your safety. Our Scientific Advisory Board and Ethics Committee oversee the disease-specific protocols to ensure the highest standards of patient safety.

BHI Therapeutic Services was formed with the mission to advance stem cell research in full regulatory conformance and in conjunction with the scientific community, while making stem cell therapy available and affordable to those suffering from disease and injury. The team includes US board certified physicians and an experienced Scientific Advisory Board to oversee the disease-specific protocols to ensure the highest standards of patient safety.

BHI Therapeutic Services leads innovation and improvements in regenerative medicine on a worldwide scale. By creating ground-breaking treatments that meet unmet medical needs and offer hope and healing to patients across the world, we aspire to revolutionize healthcare.

Excellence: BHITS aims for excellence in all areas of our work, including patient care and scientific research and development. We provide therapies that meet the highest standards of quality, safety, and efficacy.

Teamwork: We aggressively seek partnerships with top organizations, researchers, and medical professionals because we believe in the power of teamwork. Together, we can advance regenerative medicine more quickly by utilizing our pooled knowledge.

Patient-Centricity: Our approach places the needs of our patients first. Their safety, wellbeing, and accessibility to efficient therapies are our top priorities. Our primary goals are to raise the quality of life and improve the results for patients.

Innovation: BHITS welcomes innovation as a factor behind advancements in regenerative medicine. To develop the field and provide patients with novel therapies, we continuously investigate new theories, technologies, and strategies.

Ethics and Integrity: In all aspects of our business, including research and development, we uphold the highest ethical standards. In all our interactions, we uphold openness, honesty, and responsible decision-making, and we guarantee the moral use of stem cell treatments.

Global Impact: By increasing access to our therapies and working with healthcare specialists around the world, we are dedicated to having a positive global impact. Our goal is to help progress healthcare internationally and enhance patient outcomes.

BHI Therapeutic Sciences’ quest of excellence, innovation, and patient-centered care is guided by their mission, vision, and values. They demonstrate our dedication to changing the course of healthcare and altering lives through regenerative medicine.

Company Background

BHITS possesses a rich research background, with numerous publications in peer reviewed USA and international journals. We are a dedicated research institute that has been actively working for over a decade to perfect stem cell and other regenerative medicine therapies. This has culminated in the longest perfect safety record, the most peer review publications, the highest potency stem cell dose, the lowest price per dose, and 60 protocols submitted to the USA FDA pending approval.

Stem cell therapy has been shown to successfully regenerate the injured and diseased tissue without the need for medication or surgery. Patients suffering from chronic, often debilitating diseases can benefit, including those diagnosed with Alzheimer’s disease, strokes, diabetes, arthritis, heart disease, infertility, erectile dysfunction, traumatic brain injury, and over 50 other conditions. We are continually developing new protocols to help both common and rare diseases. BHITS has also pioneered a miraculous cancer immunotherapy using the patient’s own expanded dendritic and killer T-cells which have been programmed to attack the patient’s specific cancer. We have also developed a revolutionary cosmetic which uses conditioned media to regenerate skin with 32 human cytokines and growth factors obtained from our own human stem cell cultures.

BHI Therapeutic Sciences at a glance:

• 10 years of published articles in top journals in the field of stem cell research

• 60 stem cell treatment protocols submitted to the US FDA

• 9 Grant and clinical applications submitted to the USA National Institutes for Health and the Department of Defense

• Established research institute with training modules designed to educate our local team members in the highest quality cell culture techniques and research study compliance.

Our research has been published in “Experimental and Therapeutic Medicine” cited at PubMed Central, US National Library of Medicine, National Institutes of Health; and “CellR4”, the official journal of The Cure Alliance, among others.

BHI Therapeutic Sciences stem cell products are evaluated in clinical studies and are collected in accordance with Good Tissue Practice to ensure safety.

Our results show our cellular products are safe and effective in the improvement of symptoms and we have successfully treated more than 4,000 patients.